272 related articles for article (PubMed ID: 33573560)
1. The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking.
Zou T; Huang Y; Hu Y; Wu M; Zhao Y; Du F; Li M; Wu X; Ji H; Kaboli PJ; Wang S; Xiao Z; Wu Z
Recent Pat Anticancer Drug Discov; 2021; 16(3):426-435. PubMed ID: 33573560
[TBL] [Abstract][Full Text] [Related]
2. Prediction of triptolide targets in rheumatoid arthritis using network pharmacology and molecular docking.
Song X; Zhang Y; Dai E; Wang L; Du H
Int Immunopharmacol; 2020 Mar; 80():106179. PubMed ID: 31972422
[TBL] [Abstract][Full Text] [Related]
3. Triptolide is a Promising Therapeutic Approach in Treating Thyroid Cancer Based on in silico and in vitro Experiment.
Wang F; An SJ; Yin Y; Li JJ; Sun CH; Lan J; Zhao WJ; Li CQ
Drug Des Devel Ther; 2021; 15():4275-4287. PubMed ID: 34703209
[TBL] [Abstract][Full Text] [Related]
4. Triptolide exerts an anti-tumor effect on non‑small cell lung cancer cells by inhibiting activation of the IL‑6/STAT3 axis.
Huang Y; Chen Z; Wang Y; Ba X; Huang Y; Shen P; Wang H; Tu S
Int J Mol Med; 2019 Jul; 44(1):291-300. PubMed ID: 31115521
[TBL] [Abstract][Full Text] [Related]
5. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway.
Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M
Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691
[TBL] [Abstract][Full Text] [Related]
6. Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking.
Zhu N; Huang B; Zhu L; Wang Y
J Diabetes Res; 2021; 2021():9944589. PubMed ID: 34926700
[TBL] [Abstract][Full Text] [Related]
7. [Advances on effects of triptolide with non-small cell lung cancer].
Wang L; Song Y
Zhongguo Fei Ai Za Zhi; 2013 Jul; 16(7):378-81. PubMed ID: 23866670
[TBL] [Abstract][Full Text] [Related]
8. Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line.
Kim ST; Kim SY; Lee J; Kim K; Park SH; Park YS; Lim HY; Kang WK; Park JO
BMC Cancer; 2018 Nov; 18(1):1103. PubMed ID: 30419860
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro.
Hu H; Zhu S; Tong Y; Huang G; Tan B; Yang L
Anticancer Drugs; 2020 Jun; 31(5):483-491. PubMed ID: 31972592
[TBL] [Abstract][Full Text] [Related]
10. A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease.
Wang Y; Liu T; Ma F; Lu X; Mao H; Zhou W; Yang L; Li P; Zhan Y
J Diabetes Res; 2020; 2020():2421631. PubMed ID: 33274236
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology of triptolide in cancer cells: implications for transcription factor binding.
Seo EJ; Dawood M; Hult AK; Olsson ML; Efferth T
Invest New Drugs; 2021 Dec; 39(6):1523-1537. PubMed ID: 34213719
[TBL] [Abstract][Full Text] [Related]
12. ITRAQ-Based Proteomics Analysis of Triptolide On Human A549 Lung Adenocarcinoma Cells.
Li F; Zhao D; Yang S; Wang J; Liu Q; Jin X; Wang W
Cell Physiol Biochem; 2018; 45(3):917-934. PubMed ID: 29428961
[TBL] [Abstract][Full Text] [Related]
13. Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.
Banerjee S; Sangwan V; McGinn O; Chugh R; Dudeja V; Vickers SM; Saluja AK
J Biol Chem; 2013 Nov; 288(47):33927-33938. PubMed ID: 24129563
[TBL] [Abstract][Full Text] [Related]
14. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.
Liu L; Salnikov AV; Bauer N; Aleksandrowicz E; Labsch S; Nwaeburu C; Mattern J; Gladkich J; Schemmer P; Werner J; Herr I
Int J Cancer; 2014 May; 134(10):2489-503. PubMed ID: 24615157
[TBL] [Abstract][Full Text] [Related]
15. Triptolide inhibits Wnt signaling in NSCLC through upregulation of multiple Wnt inhibitory factors via epigenetic modifications to Histone H3.
Nardi I; Reno T; Yun X; Sztain T; Wang J; Dai H; Zheng L; Shen B; Kim J; Raz D
Int J Cancer; 2018 Nov; 143(10):2470-2478. PubMed ID: 30006924
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of triptolide in the treatment of connective tissue disease-related interstitial lung disease based on network pharmacology and molecular docking.
Zhu W; Li Y; Zhao J; Wang Y; Li Y; Wang Y
Ann Med; 2022 Dec; 54(1):541-552. PubMed ID: 35132912
[TBL] [Abstract][Full Text] [Related]
17. Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer.
Li LB; Yang LX; Liu L; Liu FR; Li AH; Zhu YL; Wen H; Xue X; Tian ZX; Sun H; Li PC; Zhao XG
Acta Pharmacol Sin; 2024 May; 45(5):1060-1076. PubMed ID: 38228910
[TBL] [Abstract][Full Text] [Related]
18. Triptolide induces apoptosis through the calcium/calmodulin‑dependent protein kinase kinaseβ/AMP‑activated protein kinase signaling pathway in non‑small cell lung cancer cells.
Ren T; Tang YJ; Wang MF; Wang HS; Liu Y; Qian X; Chang C; Chen MW
Oncol Rep; 2020 Nov; 44(5):2288-2296. PubMed ID: 33000264
[TBL] [Abstract][Full Text] [Related]
19. Triptolide Modulates TREM-1 Signal Pathway to Inhibit the Inflammatory Response in Rheumatoid Arthritis.
Fan D; He X; Bian Y; Guo Q; Zheng K; Zhao Y; Lu C; Liu B; Xu X; Zhang G; Lu A
Int J Mol Sci; 2016 Apr; 17(4):498. PubMed ID: 27049384
[TBL] [Abstract][Full Text] [Related]
20. Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha.
Lu N; Liu J; Liu J; Zhang C; Jiang F; Wu H; Chen L; Zeng W; Cao X; Yan T; Wang G; Zhou H; Lin B; Yan X; Zhang XK; Zeng JZ
PLoS One; 2012; 7(4):e35722. PubMed ID: 22545132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
